FI105816B - Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi Download PDF

Info

Publication number
FI105816B
FI105816B FI915933A FI915933A FI105816B FI 105816 B FI105816 B FI 105816B FI 915933 A FI915933 A FI 915933A FI 915933 A FI915933 A FI 915933A FI 105816 B FI105816 B FI 105816B
Authority
FI
Finland
Prior art keywords
aryl
asn
alkyl
alkoxy
med
Prior art date
Application number
FI915933A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI915933A (fi
FI915933A0 (fi
Inventor
Wolfgang Koenig
Stefan Muellner
Guenter Mueller
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI915933A0 publication Critical patent/FI915933A0/fi
Publication of FI915933A publication Critical patent/FI915933A/fi
Application granted granted Critical
Publication of FI105816B publication Critical patent/FI105816B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI915933A 1990-12-19 1991-12-17 Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi FI105816B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19
DE4040574 1990-12-19

Publications (3)

Publication Number Publication Date
FI915933A0 FI915933A0 (fi) 1991-12-17
FI915933A FI915933A (fi) 1992-06-20
FI105816B true FI105816B (fi) 2000-10-13

Family

ID=6420676

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915933A FI105816B (fi) 1990-12-19 1991-12-17 Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi

Country Status (24)

Country Link
US (1) US5461035A (es)
EP (1) EP0491361B1 (es)
JP (2) JP3378588B2 (es)
KR (1) KR100237948B1 (es)
AT (1) ATE177753T1 (es)
AU (1) AU643349B2 (es)
CA (1) CA2058020C (es)
CZ (1) CZ284568B6 (es)
DE (1) DE59109109D1 (es)
DK (1) DK0491361T3 (es)
ES (1) ES2130130T3 (es)
FI (1) FI105816B (es)
GR (1) GR3030510T3 (es)
HR (1) HRP940839B1 (es)
HU (1) HU222493B1 (es)
IE (1) IE914408A1 (es)
IL (1) IL100400A (es)
NO (1) NO308951B1 (es)
NZ (1) NZ241029A (es)
PT (1) PT99850B (es)
SK (2) SK282360B6 (es)
TW (1) TW227004B (es)
YU (1) YU189891A (es)
ZA (1) ZA919938B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137937T3 (es) * 1991-11-29 2000-01-01 Hoechst Ag Peptidos con efecto del tipo de insulina.
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
JP4437005B2 (ja) * 2001-01-15 2010-03-24 ソシエテ ド テクノロジー ミシュラン タイヤカーカス用造形ドラム
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (es) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
ZA919938B (en) 1992-09-30
HRP940839B1 (en) 2000-02-29
IL100400A (en) 1998-01-04
JP3378588B2 (ja) 2003-02-17
YU189891A (sh) 1995-10-03
CZ284568B6 (cs) 1999-01-13
GR3030510T3 (en) 1999-10-29
NZ241029A (en) 1993-01-27
HUT59697A (en) 1992-06-29
JP3802863B2 (ja) 2006-07-26
IL100400A0 (en) 1992-09-06
EP0491361B1 (de) 1999-03-17
JPH04295496A (ja) 1992-10-20
US5461035A (en) 1995-10-24
EP0491361A3 (en) 1993-11-24
NO914999D0 (no) 1991-12-18
FI915933A (fi) 1992-06-20
AU643349B2 (en) 1993-11-11
CS387991A3 (en) 1992-07-15
HU222493B1 (hu) 2003-07-28
PT99850A (pt) 1992-11-30
PT99850B (pt) 1999-06-30
DK0491361T3 (da) 1999-10-11
DE59109109D1 (de) 1999-04-22
SK282361B6 (sk) 2002-01-07
TW227004B (es) 1994-07-21
JP2003176237A (ja) 2003-06-24
SK282360B6 (sk) 2002-01-07
KR100237948B1 (ko) 2000-01-15
HRP940839A2 (en) 1997-06-30
ATE177753T1 (de) 1999-04-15
CA2058020C (en) 2003-10-28
NO914999L (no) 1992-06-22
IE914408A1 (en) 1992-07-01
ES2130130T3 (es) 1999-07-01
NO308951B1 (no) 2000-11-20
CA2058020A1 (en) 1992-06-20
FI915933A0 (fi) 1991-12-17
EP0491361A2 (de) 1992-06-24
KR920012115A (ko) 1992-07-25
HU914009D0 (en) 1992-03-30
AU8982591A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
EP0029579B1 (en) Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4224316A (en) Synthetic peptides having pituitary growth hormone releasing activity
FI83660C (fi) Foerfarande foer framstaellning bukspottskoertelns grf hos maenniskan.
RU2205836C2 (ru) Усовершенствованный способ получения предшественника инсулина с правильно соединенными цистиновыми мостиками
JPH0161120B2 (es)
DK167361B1 (da) Grf-analoge peptider, farmaceutisk acceptable salte heraf og fremgangsmaader til fremstilling af disse
CA1175810A (en) Synthetic peptides having pituitary growth hormone releasing activity
JPH085916B2 (ja) 新規カルシトニン誘導体
US4228155A (en) Synthetic peptides having pituitary growth hormone releasing activity
KR970009887B1 (ko) 심방의 나트륨이뇨성 펩티드의 선형유사체
US4490364A (en) CCK Agonists II
JPH0273100A (ja) 医薬用化合物
FI98731C (fi) Menetelmä superaktiivisten insuliinianalogien valmistamiseksi
FI105816B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
NO169173B (no) Veksthormon-frigjoerende peptider
US4705778A (en) Orally active LHRH analogs
JP3324804B2 (ja) インシュリン様作用を有するペプチド
Izeboud et al. Synthesis of porcine motilin via its sulfoxides
Warnke et al. Amino-acids and peptides, Part 44. Synthesis of protected peptides related to sequence 23–30 of bovine insulin B-chain
FR2458539A1 (fr) Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique
Warnke Studies in Peptide Synthesis
JPH0339518B2 (es)
PL150241B1 (pl) Sposób wytwarzania nowych pochodnych kalcytoniny